This study assessed DDFPe dose response and reduction of infarct volume at 7 and 24 h in a permanent occlusion model of stroke. Repeated doses of the drug given every 90 minutes are associated with an 85% reduction in infarct volume at 24 hours.
top of page
NuvOx Pharma
1635 E 18th Street
Tucson, Arizona 85719
© 2020 NuvOx Pharma
bottom of page
Comments